Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Clear all

759 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20018
20027
20036
200412
200513
200620
200728
200820
200925
201018
201135
201219
201337
201426
201532
201637
201733
201828
201934
202032
202145
202250
202344
202449
202528
202637

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed350
Terminated112
Recruiting95
Unknown status70
Active, not recruiting58
Withdrawn42
Not yet recruiting26
Suspended6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)41
M.D. Anderson Cancer Center17
Washington University School of Medicine14
Memorial Sloan Kettering Cancer Center13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins13
H. Lee Moffitt Cancer Center and Research Institute11
City of Hope Medical Center10
Abramson Cancer Center at Penn Medicine9
Eli Lilly and Company9
Pfizer8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms759
Colorectal Neoplasms179
Breast Neoplasms158
Stomach Neoplasms130
Carcinoma, Non-Small-Cell Lung127
Ovarian Neoplasms116
Lung Neoplasms96
Colonic Neoplasms92
Neoplasms89
Neoplasm Metastasis78

Trials

Showing 1 to 25 of 759. Each trial links to its page on Pharma Observatory.

659 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.